The US Food and Drug Administration has given approval to Lupin Pharmaceuticals to market its Irbesartan tablets in the country.
The US Food and Drug Administration has given approval to Lupin Pharmaceuticals to market its Irbesartan tablets, a generic version of Sanofi Aventis’s Avapro, in the country. The company said that it has received approval to market the Irbesartan tablets in 75-300 mg strengths.
The Avapro tablets are used in treating hypertension and nephropathy in type II diabetic patients and accounted for more than $400.7 million in annual sales, according to data from IMS health.
Source-Medindia